Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-06-18

Clinical Trial Update: Study for Treatment of Moderate or Severe, Periodic, "Cyclic", Breast Pain [Phase 3]

View source ↗

Summary

A Phase 3 trial for cyclic breast pain associated with fibrocystic breast disease is being conducted, sponsored by Symbollon Pharmaceuticals; current status is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Symbollon Pharmaceuticals | Conditions: Fibrocystic Disease of Breast, Fibrocystic Changes of Breast | Phase 3 | Status: UNKNOWN